Serum periostin (ng/ml) | Serum periostin (ng/ml) | ||
r | p-value | ||
Age, years | Age, years | -0.15 | 0.11 |
Disease duration, years | Disease duration, years | -0.06 | 0.56 |
Asthma severity | Asthma severity | 0.41 | < 0.001 |
Asthma control status | Asthma control status | -0.01 | 0.92 |
Atopic dermatitis | Atopic dermatitis | 0.11 | 0.23 |
Allergic rhinitis | Allergic rhinitis | 0.04 | 0.70 |
BMI, z-score | BMI, z-score | -0.31 | < 0.001 |
Total IgE (IU/mL) | Total IgE (IU/mL) | 0.03 | 0.78 |
Eosinophils, (%) | Eosinophils, (%) | -0.18 | 0.06 |
Eosinophils, (/ml) | Eosinophils, (/ml) | -0.18 | 0.05 |
FEV1, pred % | FEV1, pred % | 0.04 | 0.66 |
FEV1/FVC ratio | FEV1/FVC ratio | 0.10 | 0.26 |
FEF25-75, pred % | FEF25-75, pred % | 0.04 | 0.69 |
Abbreviations: BMI, body mass index; FEF25-75, forced expiratory flow between 25% and 75%; FEV1, forced expiratory volume during first second; FVC, forced vital capacity | Abbreviations: BMI, body mass index; FEF25-75, forced expiratory flow between 25% and 75%; FEV1, forced expiratory volume during first second; FVC, forced vital capacity | Abbreviations: BMI, body mass index; FEF25-75, forced expiratory flow between 25% and 75%; FEV1, forced expiratory volume during first second; FVC, forced vital capacity | Abbreviations: BMI, body mass index; FEF25-75, forced expiratory flow between 25% and 75%; FEV1, forced expiratory volume during first second; FVC, forced vital capacity |